Cargando…

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern

SARS-CoV-2 infection and/or vaccination elicit a broad range of neutralizing antibody responses against the different variants of concern (VOC). We established a new variant-adapted surrogate virus neutralization test (sVNT) and assessed the neutralization activity against the ancestral B.1 (WT) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos da Silva, Eveline, Servais, Jean-Yves, Kohnen, Michel, Arendt, Vic, Staub, Therese, Krüger, Rejko, Fagherazzi, Guy, Wilmes, Paul, Hübschen, Judith M., Ollert, Markus, Perez-Bercoff, Danielle, Seguin-Devaux, Carole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573711/ https://www.ncbi.nlm.nih.gov/pubmed/37834413 http://dx.doi.org/10.3390/ijms241914965

Ejemplares similares

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
por: da Silva, Eveline Santos, et al.
Publicado: (2022)

Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity
por: Fischer, Aurélie, et al.
Publicado: (2022)

Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg
por: Arendt, Vic, et al.
Publicado: (2019)

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
por: Meyrath, Max, et al.
Publicado: (2022)

HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG
por: Mulinge, Martin, et al.
Publicado: (2013)

Correction: HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG
por: Mulinge, Martin, et al.
Publicado: (2013)

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission
por: Santos da Silva, Eveline, et al.
Publicado: (2016)

Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate
por: Dauwe, Kenny, et al.
Publicado: (2015)

Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface
por: Arendt, Vic, et al.
Publicado: (2019)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
por: Kim, Sun Jin, et al.
Publicado: (2022)

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
por: Vaidya, Sunil R.
Publicado: (2023)

Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation
por: Adams, Philipp, et al.
Publicado: (2021)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020)

Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level
por: Wang, Xiaoli, et al.
Publicado: (2018)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
por: Liu, Jianyang, et al.
Publicado: (2022)

Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study
por: Fischer, Aurélie, et al.
Publicado: (2022)

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
por: Merluza, John, et al.
Publicado: (2023)

Some thoughts concerning neutralization and $\overline{H}$ beams
por: Weiss, M
Publicado: (1989)

The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4(+) T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice
por: Amand, Mathieu, et al.
Publicado: (2023)

Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021
por: Staub, Thérèse, et al.
Publicado: (2021)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
por: Springer, David Niklas, et al.
Publicado: (2023)

An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
por: Wohlgemuth, Nicholas, et al.
Publicado: (2021)

Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts
por: Adams, Ortwin, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
por: Valdovino-Navarro, Blanca J., et al.
Publicado: (2022)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
por: Embregts, Carmen W.E., et al.
Publicado: (2021)

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
por: Amaya, Moushimi, et al.
Publicado: (2023)

Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Banking sectors and carbon neutrality goals: mediating concern of financial inclusion
por: Sun, Chenghao, et al.
Publicado: (2023)

Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
por: Mariën, Joachim, et al.
Publicado: (2021)

Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study
por: Fagherazzi, Guy, et al.
Publicado: (2020)

Genomic Analysis of SARS-CoV-2 Alpha, Beta and Delta Variants of Concern Uncovers Signatures of Neutral and Non-Neutral Evolution
por: Kurpas, Monika Klara, et al.
Publicado: (2022)

Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease
por: Penkert, Rhiannon R., et al.
Publicado: (2021)

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
por: Chan, Kwok-Hung, et al.
Publicado: (2021)

Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers
por: Mouna, Lina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sjo0ummlrkkqqnbne6i6ej32r6